Native Cardio


Native Cardio Inc. is a late-stage medical device company dedicated to improving patient quality of life through innovative, minimally invasive, and cost-efficient solutions that address unmet healthcare needs, particularly focusing on atrial fibrillation and postoperative atrial fibrillation (POAF). The company develops advanced technologies such as low-energy cardioversion devices and targeted tissue delivery systems to treat cardiac arrhythmias effectively and safely.

Industries

health-care
medical
medical-device

Nr. of Employees

small (1-50)

Native Cardio

Naples, Florida, United States, North America


Products

Ultra‑low energy atrial cardioversion and targeted delivery system

A medical device concept designed to deliver ultra‑low electrical cardioversion energy and optionally localized drug therapy directly to atrial tissue via a transthoracic approach to treat postoperative atrial fibrillation.


Services

Clinical collaboration and investigator‑sponsored research support

Partnerships with clinical investigators and health technology companies to support clinical studies, monitoring and combined diagnostic‑therapeutic workflows.

Expertise Areas

  • Clinical trial management and investigator-sponsored research
  • Cardiac rhythm management and atrial fibrillation treatment
  • Medical device research and systems engineering
  • Transthoracic targeted tissue delivery
  • Show More (4)

Key Technologies

  • Ultra-low-energy cardioversion
  • Transthoracic targeted tissue drug delivery
  • Direct atrial tissue delivery systems
  • Wireless ECG patch monitoring integration
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.